| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.03 |